Efficacy and safety of dexmedetomidine versus haloperidol for treatment of postoperative agitated delirium in liver transplant recipients

Trial Profile

Efficacy and safety of dexmedetomidine versus haloperidol for treatment of postoperative agitated delirium in liver transplant recipients

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2016

At a glance

  • Drugs Dexmedetomidine (Primary) ; Haloperidol; Haloperidol
  • Indications Delirium
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jun 2016 New trial record
    • 01 May 2016 Results published in the Transplantation Proceedings
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top